Transcatheter Mitral Valve Replacement (TMVR)
Mitral Valve Disease
Pre-clinicalActive
Key Facts
About Capstan Medical
Capstan Medical is a private, pre-revenue medical device startup founded in 2021 and based in Santa Clara, California, with an R&D office in Santa Cruz. The company is developing an integrated platform that combines robotics, catheter technology, and novel implants to enable minimally invasive replacement of mitral and tricuspid heart valves, areas with no currently FDA-approved transcatheter replacement options. Led by a seasoned team with deep experience in cardiac devices and surgical robotics, Capstan aims to transform the standard of care for structural heart disease by reducing procedural invasiveness, improving precision, and shortening patient recovery times.
View full company profileTherapeutic Areas
Other Mitral Valve Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Innovalve Transcatheter Mitral Valve Replacement | Clinical Accelerator | First-in-Human (FIH) |